captopril has been researched along with cilazapril, anhydrous in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (18.75) | 18.7374 |
1990's | 24 (75.00) | 18.2507 |
2000's | 2 (6.25) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 2 |
Rabkin, SW | 1 |
Blöchl-Daum, B; Brenner, B; Eichler, HG; Gasic, S; Kyrle, PA; Lechner, K; Schneider, B; Wagner, B | 1 |
Baumgartner, HR; Clozel, M; Hefti, F; Kuhn, H | 1 |
Baumgartner, HR; Hefti, F; Kuhn, H; Müller, RK; Powell, JS; Rouge, M | 1 |
Clozel, M | 1 |
Clozel, JP; Hess, P; Sprecher, U; Véniant, M | 1 |
Clozel, M; Hefti, F; Kuhn, H | 1 |
Inagami, T; Mikami, H; Nakamaru, M; Ogihara, T; Rakugi, H; Saito, H | 1 |
Belz, GG; Essig, J; Wellstein, A | 3 |
Brunner, HR; Nussberger, J; Waeber, B | 1 |
Goldszer, RC; Lilly, LS; Solomon, HS | 1 |
Attwood, MR; Francis, RJ; Hassall, CH; Kröhn, A; Lawton, G; Natoff, IL; Nixon, JS; Redshaw, S; Thomas, WA | 1 |
Arnold, C; Gábeli, T; Juhász, A; Karányi, Z; Kovács, P; Lörincz, I; Paragh, G; Polgár, P | 1 |
Ikeda, U; Shimada, K | 1 |
Borbujo, J; Casado, M; Fernández-Díaz, ML; Herranz, P; Manzano, R; Suárez-Marrero, MC | 1 |
Belz, GG; Breithaupt, K; Erb, K | 1 |
Bertossi, M; Nico, B; Pirrelli, A; Ricci, S; Roncali, L; Seccia, T; Vulpis, V | 2 |
Chideckel, EW; Stevenson, JG | 1 |
Bonagura, F; Ciulla, M; Magrini, F; Paliotti, R; Reggiani, P; Vandoni, P | 1 |
Schneeweiss, A | 1 |
Reisin, L | 1 |
Nico, B; Pirrelli, A; Ricci, S; Roncali, L; Seccia, TM; Vulpis, V | 1 |
Bouwer, CD; Hawkridge, SM; Stein, DJ | 1 |
Bulpitt, CJ; Dössegger, L; Fletcher, AE; Neiss, A; Nielsen, T; Viergutz, S | 1 |
3 review(s) available for captopril and cilazapril, anhydrous
Article | Year |
---|---|
ACE-inhibitors and atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats | 1992 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Ace-inhibitors and experimental atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Captopril; Cilazapril; Endothelium, Vascular; Humans | 1993 |
10 trial(s) available for captopril and cilazapril, anhydrous
Article | Year |
---|---|
Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Adult; Bleeding Time; Blood Platelets; Blood Pressure; Captopril; Cilazapril; Double-Blind Method; Epoprostenol; Heart Rate; Humans; Male; Radioimmunoassay; Random Allocation; Thromboxane B2 | 1992 |
Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.
Topics: Administration, Oral; Adolescent; Adult; Angiotensin I; Blood Pressure; Captopril; Cilazapril; Diastole; Dose-Response Relationship, Drug; Enalapril; Humans; Male; Pyridazines; Systole; Vascular Resistance | 1987 |
The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cilazapril; Dose-Response Relationship, Drug; Enalapril; Humans; Peptidyl-Dipeptidase A; Pyridazines; Time Factors; Vascular Resistance | 1989 |
Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cilazapril; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Humans; Male; Pyridazines; Random Allocation; Time Factors | 1987 |
[Cilazapril replacing captopril in the therapy of medium-severe essential hypertension].
Topics: Administration, Oral; Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Captopril; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Hungary; Hypertension; Male; Middle Aged; Patient Compliance; Severity of Illness Index | 1995 |
Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Chronic Disease; Cilazapril; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged | 1995 |
Review of studies on the clinical pharmacodynamics of cilazapril.
Topics: Administration, Oral; Aged; Angiotensin I; Blood Pressure; Captopril; Cardiac Output; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Half-Life; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol | 1994 |
Evaluation of cilazapril versus captopril in patients with mild to moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Cilazapril; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 1994 |
[Therapy conversion to cilazapril in angiotensin conversion enzyme inhibitor-induced cough. Evaluation of the effect].
Topics: Adult; Aged; Captopril; Cilazapril; Cough; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 1993 |
Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cilazapril; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life | 1998 |
19 other study(ies) available for captopril and cilazapril, anhydrous
Article | Year |
---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cilazapril and captopril accelerate recovery from hypoxia in myocardial cell aggregates in culture.
Topics: Allopurinol; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Aggregation; Cell Hypoxia; Cells, Cultured; Chick Embryo; Cilazapril; Free Radicals; Heart; Myocardial Contraction; Myocardium; Oxygen; Pyridazines | 1992 |
Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Carotid Arteries; Cell Movement; Cilazapril; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Macrophages; Male; Norepinephrine; Peptidyl-Dipeptidase A; Pyridazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Serotonin; Vasoconstriction; Vasodilation | 1991 |
The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Cell Division; Cilazapril; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Growth Substances; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pyridazines; Rats; Verapamil | 1990 |
Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Cilazapril; Endothelium, Vascular; Hypertension; Male; Methylene Blue; Nitric Oxide; Pyridazines; Rats; Rats, Inbred SHR; Serotonin; Thromboxanes; Vasoconstriction | 1991 |
Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Cilazapril; Coronary Circulation; Dose-Response Relationship, Drug; Hydralazine; Hypertension; Male; Perfusion; Pyridazines; Rats; Rats, Inbred SHR | 1991 |
Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cilazapril; Endothelium, Vascular; Hydralazine; Hypertension; Indomethacin; Male; Pyridazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin | 1990 |
Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Cilazapril; Enalapril; Male; Mesenteric Arteries; Perfusion; Pyridazines; Ramipril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Thiazepines | 1990 |
Prevalence of cough during angiotensin-converting enzyme inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cilazapril; Cough; Enalapril; Female; Humans; Male; Pharynx; Pyridazines | 1988 |
New potent inhibitors of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Cilazapril; Dipeptides; Enalapril; Humans; Molecular Conformation; Proline; Pyridazines; Rabbits; Structure-Activity Relationship; Swine | 1984 |
Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Captopril; Cells, Cultured; Cilazapril; Enalaprilat; Enzyme Induction; Humans; Interleukin-1; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger; Transcription, Genetic | 1994 |
Subacute cutaneous lupus erythematosus associated with cilazapril.
Topics: Captopril; Cilazapril; Female; Humans; Hypertension; Lupus Erythematosus, Cutaneous; Middle Aged | 1995 |
Left-ventricular hypertrophy in the spontaneously hypertensive rat: effect of ACE inhibitors on ultrastructural morphology.
Topics: Animals; Blood Pressure; Captopril; Cilazapril; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Microscopy, Electron; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Coronary hemodynamics and the renin angiotensin system.
Topics: Adult; Angiotensin II; Captopril; Cilazapril; Coronary Circulation; Furosemide; Hemodynamics; Humans; Hypertension, Renovascular; Infusions, Intravenous; Male; Middle Aged; Renin-Angiotensin System | 1993 |
[Left ventricular hypertrophy in spontaneously hypertensive rats: effect of angiotensin converting enzyme inhibitors on morphologic ultrastructure].
Topics: Animals; Captopril; Cilazapril; Dose-Response Relationship, Drug; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Microscopy, Electron; Mitochondria, Heart; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar | 1993 |
[Angiotensin converting enzyme inhibitor-induced cough: patterns and incidence. Consequences for continuation of therapy].
Topics: Aged; Captopril; Cilazapril; Cough; Enalapril; Female; Heart Failure; Humans; Hypertension; Long-Term Care; Male; Middle Aged | 1993 |
Left ventricular hypertrophy in spontaneously hypertensive rat: effects of ACE-inhibition on myocardiocyte ultrastructure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Cilazapril; Heart Rate; Hypertension; Hypertrophy; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Ventricular Function, Left | 1995 |
Exacerbation of respiratory symptoms in patients with panic disorder.
Topics: 1-Naphthylamine; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cilazapril; Citalopram; Comorbidity; Drug Interactions; Female; Humans; Hypertension; Male; Middle Aged; Panic Disorder; Respiration Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |